Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06315972
What this trial is testing

Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity

Who this might be right for
Schizophrenia
LMU Klinikum 90
Not applicableStudy completedNCT03514212
What this trial is testing

Promoting Physical Activity in People With Schizophrenia.

Who this might be right for
Schizophrenia
University of Edinburgh 20
Testing effectiveness (Phase 2)Study completedNCT00825539
What this trial is testing

Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 68
Testing effectiveness (Phase 2)Looking for participantsNCT04917302
What this trial is testing

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT00660595
What this trial is testing

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

Who this might be right for
Schizophrenic Disorders
AstraZeneca 29
Not applicableUnknownNCT00698295
What this trial is testing

Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication

Who this might be right for
Schizophrenia
Seoul National University Hospital 60
Large-scale testing (Phase 3)Study completedNCT01469039
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 623
Post-approval studies (Phase 4)Study completedNCT02075528
What this trial is testing

Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ER

Who this might be right for
SchizophreniaSchizoaffective Disorder
Taipei City Hospital 41
Large-scale testing (Phase 3)Study completedNCT00864045
What this trial is testing

Sertindole in Asian Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 394
Very early researchUnknownNCT06235177
What this trial is testing

Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues

Who this might be right for
Schizoaffective Disorder, Bipolar TypeBipolar DisorderADHD - Combined Type+5 more
The Essence of Integrative Health and Medicine Practice 30
Not applicableStudy completedNCT04665401
What this trial is testing

Personalizing Interventions Using Real-World Interactions

Who this might be right for
Social InteractionSchizophrenia Spectrum and Other Psychotic Disorders
Indiana University 34
Not applicableUnknownNCT05945277
What this trial is testing

Critical Time Intervention-Peer Support

Who this might be right for
Psychotic DisordersSchizophreniaBipolar Disorder+1 more
Lisbon Institute of Global Mental Health - LIGMH 60
Not applicableUnknownNCT02322918
What this trial is testing

The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder

Who this might be right for
PsychosisSchizophrenia
University of British Columbia 200
Early research (Phase 1)Study completedNCT04709224
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 37
Not applicableNot Yet RecruitingNCT07393464
What this trial is testing

PQQ for Cognitive and Negative Symptoms

Who this might be right for
SchizophreniaCognitive SymptomsNegative Symptoms
Tianjin Anding Hospital 70
Post-approval studies (Phase 4)Study completedNCT01246232
What this trial is testing

Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia

Who this might be right for
Schizophrenia
Imperial College London 69
Not applicableStudy completedNCT01133587
What this trial is testing

Patient Guided Psychiatric Admissions

Who this might be right for
SchizophreniaBipolar Disorder
St. Olavs Hospital 53
Testing effectiveness (Phase 2)Ended earlyNCT01568216
What this trial is testing

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Who this might be right for
Schizophrenia
Amgen 121
Early research (Phase 1)Study completedNCT01074632
What this trial is testing

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

Who this might be right for
Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
Sumitomo Pharma America, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT01354132
What this trial is testing

N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis

Who this might be right for
Schizophrenic Psychoses
Beth Israel Deaconess Medical Center 20
Next Page